ALS drug trial halted: no clear benefit seen
NCT ID NCT06441682
First seen Nov 20, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tested an experimental drug called ARGX-119 in 60 adults with ALS to see if it was safe and could slow the disease. The trial was stopped early because early results showed the drug was unlikely to help patients meaningfully. No safety concerns caused the early stop, and researchers are still following up with participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitets Hospital
Aarhus, 8200, Denmark
-
Akademiskt specialistcentrum Karolinska Institutet
Stockholm, 113 61, Sweden
-
Bispebjerg University Hospital
Copenhagen, 2400, Denmark
-
CHU Bretonneau
Tours, 37000, France
-
Hôpital La Pitié Salpêtrière
Paris, 75013, France
-
Kaye Edmonton Clinic
Edmonton, 11400, Canada
-
Montreal Neurological Institute and Hospital
Montreal, H3A 2B4, Canada
-
UMC Utrecht
Utrecht, 3584 CX, Netherlands
-
UZ Leuven
Leuven, 3000, Belgium
Conditions
Explore the condition pages connected to this study.